SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000831547-19-000018
Filing Date
2019-04-11
Accepted
2019-04-11 16:01:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D/A spectrum-casischedule13dxa.htm SC 13D/A 124617
2 EXHIBIT 99.1 exhibit991toschedule13da.htm EX-99.1 6303
  Complete submission text file 0000831547-19-000018.txt   132807
Mailing Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052
Business Address 11500 S. EASTERN AVE., SUITE 240 HENDERSON NV 89052 702-835-6300
SPECTRUM PHARMACEUTICALS INC (Filed by) CIK: 0000831547 (see all company filings)

IRS No.: 930979187 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Subject) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-46247 | Film No.: 19743797
SIC: 2836 Biological Products, (No Diagnostic Substances)